Daniah A. D. Thompson

Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering

Maria Vanegas, M. Llano, Maria Vanegas, 2005, Journal of Cell Science.

Differential Inhibition of Human Immunodeficiency Virus Type 1 Fusion, gp120 Binding, and CC-Chemokine Activity by Monoclonal Antibodies to CCR5

William C. Olson, Yong Guo, Jeremy P. Segal, 1999, Journal of Virology.

Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75.

M. Llano, Maria Vanegas, E. Poeschla, 2006, Journal of molecular biology.

CCR5 and CXCR4 Usage by Non-Clade B Human Immunodeficiency Virus Type 1 Primary Isolates

Daniah A. D. Thompson, T. Dragic, E. Cormier, 2002, Journal of Virology.

CCR5-Mediated Human Immunodeficiency Virus Entry Depends on an Amino-Terminal gp120-Binding Site and on the Conformational Integrity of All Four Extracellular Domains

Yong Guo, Daniah A. D. Thompson, Yong Guo, 1999, Journal of Virology.

Human immunodeficiency virus type 1 entry inhibitors PRO 542 and T-20 are potently synergistic in blocking virus-cell and cell-cell fusion.

D. Thompson, W. Olson, Daniah A. D. Thompson, 2001, The Journal of infectious diseases.

A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5.

S. O. Smith, S W Lin, A. Trkola, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120.

S W Lin, S. W. Lin, D. Thompson, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domain and the second extracellular loop of CXCR4.

D. Thompson, Daniah A. D. Thompson, T. Dragic, 2000, Virology.